- Home
- DNTH vs GDRX Comparison
DNTH vs GDRX Comparison
Compare DNTH & GDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNTH
- GDRX
- Stock Information
- Founded
- DNTH 2015
- GDRX 2011
- Country
- DNTH United States
- GDRX United States
- Employees
- DNTH N/A
- GDRX N/A
- Industry
- DNTH Biotechnology: Pharmaceutical Preparations
- GDRX Retail: Computer Software & Peripheral Equipment
- Sector
- DNTH Health Care
- GDRX Technology
- Exchange
- DNTH Nasdaq
- GDRX Nasdaq
- Market Cap
- DNTH 1.4B
- GDRX 1.4B
- IPO Year
- DNTH N/A
- GDRX 2020
- Fundamental
- Price
- DNTH $33.73
- GDRX $3.33
- Analyst Decision
- DNTH Strong Buy
- GDRX Buy
- Analyst Count
- DNTH 11
- GDRX 8
- Target Price
- DNTH $65.22
- GDRX $5.75
- AVG Volume (30 Days)
- DNTH 503.3K
- GDRX 5.2M
- Earning Date
- DNTH 11-05-2025
- GDRX 11-04-2025
- Dividend Yield
- DNTH N/A
- GDRX N/A
- EPS Growth
- DNTH N/A
- GDRX N/A
- EPS
- DNTH N/A
- GDRX 0.09
- Revenue
- DNTH $4,854,000.00
- GDRX $800,651,000.00
- Revenue This Year
- DNTH N/A
- GDRX $2.72
- Revenue Next Year
- DNTH N/A
- GDRX $5.30
- P/E Ratio
- DNTH N/A
- GDRX $38.50
- Revenue Growth
- DNTH 17.87
- GDRX 1.30
- 52 Week Low
- DNTH $13.37
- GDRX $3.21
- 52 Week High
- DNTH $40.16
- GDRX $6.28
- Technical
- Relative Strength Index (RSI)
- DNTH 47.36
- GDRX 34.53
- Support Level
- DNTH $32.28
- GDRX $3.21
- Resistance Level
- DNTH $35.40
- GDRX $3.55
- Average True Range (ATR)
- DNTH 1.62
- GDRX 0.17
- MACD
- DNTH -0.20
- GDRX -0.06
- Stochastic Oscillator
- DNTH 27.78
- GDRX 14.29
About DNTH Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.
About GDRX GoodRx Holdings Inc.
GoodRx Holdings Inc is a consumer-focused digital healthcare platform that aims to lower the cost of healthcare in the United States. It operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and provides access to negotiated prices through codes that can be used to save money on prescriptions across the United States. GoodRx generates revenue from core business from pharmacy benefit managers (PBMs) that manage formularies and prescription transactions including establishing pricing between consumers and pharmacies. It also offers various healthcare products and services, including pharma manufacturer solutions, subscriptions, and telehealth services.